Status:
RECRUITING
AI-Assisted Treatment for Residual Speech Sound Disorders
Lead Sponsor:
Syracuse University
Collaborating Sponsors:
National Institutes of Health (NIH)
State University of New York - Upstate Medical University
Conditions:
Speech Sound Disorder
Eligibility:
All Genders
9-17 years
Phase:
NA
Brief Summary
The goal of this randomized-controlled trial is to determine how artificial intelligence-assisted home practice may enhance speech learning of the "r" sound in school-age children with residual speech...
Detailed Description
Artificial Intelligence-assisted treatment that detects mispronunciations within an evidence-based motor learning framework could increase access to sufficiently intense, efficacious treatment despite...
Eligibility Criteria
Inclusion
- Must speak a rhotic dialect of American English as a dominant language.
- Must have begun learning English by at least the age of 3 years.
- Must be between 9;0 to 17;11 years of age.
- Must have reported difficulty with /ɹ/ production.
- Must have reported hearing within normal limits.
- Must receive a Scaled Score of 5 or above on both the Listening Comprehension and Story Retelling subtests from the Test of Integrated Language \& Literacy Skills (TILLS).
- Must receive a percentile score of 8 or below on the Goldman-Fristoe Test of Articulation-3 (GFTA-3) Sounds in Words subtest.
- Must have 1 scorable response with 5+ consecutive correct /pataka/ with \> 3.4 syllables per second in the MRR-Tri task of the Maximum Performance Tasks OR must demonstrate no childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.
- Must score \<40% accurate based on word-level items from our /ɹ/ probe list.
- Must score \>=15% accuracy on /ɹ/ on 45 syllables following Dynamic Assessment.
- Must express interest in changing their /ɹ/ production.
- Must have oral structure and function that are appropriate for /ɹ/ production.
- Must have access to broadband internet with videoconferencing capabilities
Exclusion
- Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke.
- Must not have diagnosis of attention deficit disorder, attention deficit hyperactivity disorder, Tourette's, or Obsessive-compulsive disorder.
- Must have no orthodontic appliances that block the roof of the mouth (e.g., palate expanders).
- Must not have current cleft palate, fluency disorder, or voice disorder.
- Must not demonstrate childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.
Key Trial Info
Start Date :
September 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT05988515
Start Date
September 5 2024
End Date
December 31 2027
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Syracuse University
Syracuse, New York, United States, 13244